| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $122.3M | +2.0% | — |
| Cost of Revenue | $47.4M | -7.5% | — |
| Gross Profit | $74.9M | +9.0% | — |
| R&D Expense | $2.9M | +11.5% | +12.6% |
| SG&A Expense | $21.0M | +11.2% | +14.6% |
| Operating Income | -$107.9M | +73.7% | — |
| Pre-tax Income | -$109.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.3M | -25.0% | — |
| Short-term Investments | $0 | — | — |
| Accounts Receivable | $82.3M | +5.5% | — |
| Current Assets | $161.8M | -3.9% | — |
| Total Assets | $987.4M | -9.9% | — |
| Current Liabilities | $143.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.6M | — | — |
| Capital Expenditures | $212K | — | — |
| Investing Cash Flow | $62.6M | — | — |
| Financing Cash Flow | -$297.7M | — | — |
| Free Cash Flow | $4.4M | — | — |
| — |
| Income Tax | -$33.0M | -68.2% | — |
| Net Income | -$76.8M | +80.7% | — |
| EPS (Basic) | -$1.07 | +80.8% | — |
| EPS (Diluted) | -$1.07 | +80.8% | — |
| -18.2% |
| — |
| Total Liabilities | $389.5M | -9.0% | — |
| Stockholders' Equity | $597.9M | -10.6% | — |